Pre-operative intravenous dexamethasone prevents auditory threshold shift in a guinea pig model of cochlear implantation

Audiology and Neurotology

Volumn 16, Issue 3, 2011, Pages 137-144

  Connolly, Timothy M ^a,b   Eastwood, Hayden ^a   Kel, Gordana ^a   Lisnichuk, Halina ^a   Richardson, Rachael ^a,c   O'Leary, Stephen ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^c BIONIC EAR INSTITUTE   (Australia)

Author keywords

Cochlear implantation; Corticosteroid; Dexamethasone; Pharmacokinetic; Residual hearing; Systemic delivery

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ANIMAL; ARTICLE; DRUG EFFECT; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HEARING; IMPLANTATION; PHYSIOLOGY;

ANIMALS; COCHLEAR IMPLANTATION; DEXAMETHASONE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GLUCOCORTICOIDS; GUINEA PIGS; HEARING;

EID: 77954932800     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000314757     Document Type: Article

References (41)

1. Balcer LJ: Clinical practice. Optic neuritis. N Engl J Med 2006; 354: 1273-1280.
2. Balkany TJ, Connell SS, Hodges AV, Payne SL, Telischi FF, Eshraghi AA, Angeli SI, Germani R, Messiah S, Arheart KL: Conservation of residual acoustic hearing after co-chlear implantation. Otol Neurotol 2006; 27: 1083-1088. (Pubitemid 44863730)
3. Banerjee A, Hawthorne MR, Flood LM, Martin FW: Audit of stapedectomy results in a dis-trict general hospital. Clin Otolaryngol Al-lied Sci 2002; 27:275-278. (Pubitemid 36005535)
4. Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ: Intratympanic versus intra-venous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007; 28: 1124-1130. (Pubitemid 350191089)
5. Center for Drug Evaluation and Research: Esti-mating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Food and Drug Administration, Rockville; 2005.
6. Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, Baredes S: Dexamethasone pharmacokinetics in the in-ner ear: comparison of route of administra-tion and use of facilitating agents. Otolaryn-gol Head Neck Surg 2000; 122:521-528. (Pubitemid 30210667)
7. Chang A, Eastwood H, Sly D, James D, Richardson R, O'Leary S: Factors influencing the ef-ficacy of round window dexamethasone pro-tection of residual hearing post-cochlear implant surgery. Hear Res 2009; 255:67-72.
8. Cochrane AB, Husain AN, Anderson AS, Kim AY, Fedson SE: Increased rejection rates in cardiac transplant associated with dexa-methasone. Steroids 2008; 73: 441-448.
9. Cohen NL: Cochlear implant candidacy and surgical considerations. Audiol Neurootol 2004; 9: 197-202. (Pubitemid 38812967)
10. Copeland BJ, Pillsbury HC 3rd: Cochlear im-plantation for the treatment of deafness. Annu Rev Med 2004; 55:157-167.
11. Cullen RD, Higgins C, Buss E, Clark M, Pills-bury HC 3rd, Buchman CA: Cochlear im-plantation in patients with substantial re-sidual hearing. Laryngoscope 2004; 114: 2218-2223. (Pubitemid 39602493)
12. Dowell RC, Hollow R, Winton E: Outcomes for cochlear implant users with significant re-sidual hearing: implications for selection cri-teria in children. Arch Otolaryngol Head Neck Surg 2004; 130: 575-581. (Pubitemid 38609667)
13. Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, Van De Water TR: Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-in-duced hearing loss. Otol Neurotol 2007; 28: 842-849. (Pubitemid 47329902)
14. Gantz BJ, Turner C, Gfeller KE, Lowder MW: Preservation of hearing in cochlear implant surgery: advantages of combined electrical and acoustical speech processing. Laryngo-scope 2005; 115: 796-802. (Pubitemid 40604682)
15. Gstoettner W, Kiefer J, Baumgartner WD, Pok S, Peters S, Adunka O: Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol 2004; 124: 348-352. (Pubitemid 38797582)
16. Gstoettner WK, Van De Heyning P, O'Connor AF, Morera C, Sainz M, Vermeire K, McDon-ald S, Cavalle L, Helbig S, Valdecasas JG, An-derson I, Adunka OF: Electric acoustic stim-ulation of the auditory system: results of a multi-centre investigation. Acta Otolaryn-gol 2008: 1-8.
17. James C, Albegger K, Battmer R, Burdo S, Deg-gouj N, Deguine O, Dillier N, Gersdorff M, Laszig R, Lenarz T, Rodriguez MM, Mon-dain M, Offeciers E, Macias AR, Ramsden R Sterkers O, Von Wallenberg E, Weber B, Fraysse B: Preservation of residual hearing with cochlear implantation: how and why. Acta Otolaryngol 2005; 125:481-491. (Pubitemid 40676887)
18. James DP, Eastwood H, Richardson RT, O'Leary SJ: Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurootol 2008; 13: 86-96. (Pubitemid 351225887)
19. Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, von Ilberg C: Conservation of low-frequency hearing in cochlear implanta-tion. Acta Otolaryngol 2004; 124:272-280. (Pubitemid 38580856)
20. Kiefer J, Pok M, Adunka O, Sturzebecher E, Baumgartner W, Schmidt M, Tillein J, Ye Q, Gstoettner W: Combined electric and acous-tic stimulation of the auditory system: results of a clinical study. Audiol Neurootol 2005; 10: 134-144. (Pubitemid 40663391)
21. Kiefer J, von Ilberg C, Reimer B, Knecht R, Gall V Diller G, Sturzebecher E, Pfennigdorff T, Spelsberg A: Results of cochlear implanta-tion in patients with severe to profound hear-ing loss-implications for patient selection. Audiology 1998; 37: 382-395. (Pubitemid 29017207)
22. Kopke R Allen KA, Henderson D, Hoffer M, Frenz D, Van de Water T: A radical demise: toxins and trauma share common pathways in hair cell death. Ann NY Acad Sci 1999; 884:171-191.
23. Lehnhardt E: Intracochlear placement of cochle-ar implant electrodes in soft surgery tech-nique (in German). HNO 1993; 41:356-359.
24. Lenarz T, Stover T, Buechner A, Paasche G, Briggs R, Risi F, Pesch J, Battmer RD: Tem-poral bone results and hearing preservation with a new straight electrode. Audiol Neu-rootol 2006; 11(suppl 1):34-41. (Pubitemid 44629841)
25. Ma C, Billings P, Harris JP, Keithley EM: Char-acterization of an experimentally induced inner ear immune response. Laryngoscope 2000; 110:451-456. (Pubitemid 30143693)
26. Maini S, Lisnichuk H, Eastwood H, Pinder D, James D, Richardson RT, Chang A, Connolly T, Sly D, Kel G, O'Leary SJ: Targeted therapy of the inner ear. Audiol Neurootol 2009; 14: 402-410.
27. Parnes LS, Sun AH, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical applica-tion. Laryngoscope 1999; 109:1-17. (Pubitemid 29315126)
28. Plontke SK, Biegner T, Kammerer B, Delabar U, Salt AN: Dexamethasone concentration gra-dients along scala tympani after application to the round window membrane. Otol Neu-rotol 2008; 29:401-406. (Pubitemid 351450804)
29. Reagan-Shaw S, Nihal M, Ahmad N: Dose trans-lation from animal to human studies revis-ited. FASEB J 2008; 22:659-661. (Pubitemid 351348146)
30. Shepherd RK, Clark GM: Progressive ototoxicity of neomycin monitored using derived brain-stem response audiometry. Hear Res 1985; 18: 105-110. (Pubitemid 15003783)
31. Strupp M, Zingler VC, Arbusow V Niklas D, Maag KP, Dieterich M, Bense S, Theil D, Jahn K, Brandt T: Methylprednisolone, valacyclo-vir, or the combination for vestibular neuri-tis. N Engl J Med 2004; 351: 354-361.
32. Tanaka H, Hirano F, Nomura Y, Miura T, Maki-no Y, Fukawa E, Makino I: Relative glucocor-ticoid potency revisited. Rheumatol Int 1994; 14: 9-12.
33. Tobita T, Senarita M, Hara A, Kusakari J: Deter-mination of prednisolone in the cochlear tis-sue. Hear Res 2002; 165: 30-34.
34. Turner CW, Reiss LA, Gantz BJ: Combined acoustic and electric hearing: preserving re-sidual acoustic hearing. Hear Res 2008;242: 164-171.
35. Vivero RJ, Joseph DE, Angeli S, He J, Chen S, Eshraghi AA, Balkany TJ, Van de Water TR: Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope 2008; 118:2028-2035.
36. Von Ilberg C, Kiefer J, Tillein J, Pfenningdorff T, Hartmann R, Sturzebecher E, Klinke R: Electric-acoustic stimulation of the auditory system. New technology for severe hearing loss. ORL J Otorhinolaryngol Relat Spec 1999; 61:334-340. (Pubitemid 29515564)
37. Warren A, King L: A review of the efficacy of dexamethasone in the prevention of postop-erative nausea and vomiting. J Clin Nurs 2008; 17: 58-68.
38. Wei BP, Mubiru S, O'Leary S: Steroids for idio-pathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2006: CD003998.
39. Wilson WR Byl FM, Laird N The efficacy of ste-roids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980; 106:772-776. (Pubitemid 11194190)
40. Xu SA, Shepherd RK, Chen Y, Clark GM: Pro-found hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid. Hear Res 1993; 70:205-215. (Pubitemid 23353182)
41. Zou J, Poe D, Bjelke B, Pyykko I: Visualization of inner ear disorders with MRI in vivo: from animal models to human application. Acta Otolaryngol Suppl 2009; 22-31.